Publications by authors named "Kenneth Thurston"

Claim this Profile
H
Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with Y Radioembolization.
Kazim H Narsinh, Mark Van Buskirk, Andrew S Kennedy, Mohammed Suhail, Naif Alsaikhan, Kenneth Thurston

Radiology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.
Guy A van Hazel, Volker Heinemann, Navesh K Sharma, Michael P N Findlay, Jens Ricke, Kenneth Thurston

J Clin Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
Peter Gibbs, Val Gebski, Mark Van Buskirk, Kenneth Thurston, David N Cade

BMC Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
Mercedes Iñarrairaegui, Kenneth G Thurston, Jose I Bilbao, Delia D'Avola, Macarena Rodriguez

J Vasc Interv Radiol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
Kent T Sato, Robert J Lewandowski, Mary F Mulcahy, Bassel Atassi, Robert K Ryu, Kenneth G Thurston

Radiology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.
Riad Salem, Kenneth G Thurston

J Vasc Interv Radiol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
Riad Salem, Kenneth G Thurston

J Vasc Interv Radiol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.
Riad Salem, Kenneth G Thurston

J Vasc Interv Radiol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
Riad Salem, Robert J Lewandowski, Bassel Atassi, Stuart C Gordon, Vanessa L Gates, Kenneth G Thurston

J Vasc Interv Radiol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
Robert J Lewandowski, Kenneth G Thurston, James E Goin, Ching-Yee O Wong, Vanessa L Gates

J Vasc Interv Radiol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiographic considerations in patients undergoing liver-directed therapy.
David M Liu, Riad Salem, James T Bui, Angi Courtney, Omar Barakat, Kenneth G Thurston

J Vasc Interv Radiol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
James E Goin, Riad Salem, Brian I Carr, Janet E Dancey, Michael C Soulen, Kenneth Thurston

J Vasc Interv Radiol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.
James E Goin, Riad Salem, Brian I Carr, Janet E Dancey, Michael C Soulen, Kenneth Thurston

J Vasc Interv Radiol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.
Jean Francois H Geschwind, Riad Salem, Brian I Carr, Michael C Soulen, Kenneth G Thurston

Gastroenterology· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.
Riad Salem, Robert Lewandowski, Carol Roberts, James Goin, Kenneth Thurston

J Vasc Interv Radiol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer.
Riad Salem, Kenneth G Thurston, Brian I Carr, James E Goin, Jean-Francois H Geschwind

J Vasc Interv Radiol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis